Chlamydophila-felis-Infektion bei Katzen

Zusammenfassung

Chlamydophila felis ist ein bei Katzen weit verbreiteter Erreger, der bei bis zu 60% der Katzen mit Konjunktivitis oder Katzenschnupfen vorkommt. Die Verbreitung erfolgt nicht nur durch klinisch kranke Katzen; auch asymptomatische Träger scheiden den Erreger aus. Die Behandlung der Infektion ist insofern problematisch, als es sich häufig um Katzen handelt, die im engen Kontakt zu anderen infizierten Katzen leben, und somit die Gefahr einer permanenten Reinfektion besteht. Zudem müssen die verabreichten Antibiotika bestimmte Anforderungen erfüllen, wie z. B. eine gute intrazelluläre Wirksamkeit, da der Erreger obligat intrazellulär vorkommt. Mit diesem Übersichtsartikel sollen verschiedene Therapieschemata und Managementoptionen bei Katzen mit Katzenschnupfen beschrieben, verglichen und kritisch gegenübergestellt werden.

Summary

Chlamydophila felis is a common organism among cats and has been detected in up to 60% of cats with conjunctivitis or upper respiratory tract disease. Transmission is mainly caused by direct contact to symptomatic cats. Nevertheless, carriers without current clinical signs are able to shed the organism and, therefore, are a source of infection as well. Treatment and management of infection may be difficult as cats often live in close contact with shedding cats. The most common problem in multi-cat households is re-infection. The intracellular occurrence of Chlamydophila felis requires antibiotics that exhibit a good intracellular efficacy. In this review article, currently used treatment and management regimes are described and compared to each other.

Schlüsselwörter

Chlamydien - Konjunktivitis - Katzenschnupfen - Behandlung

Key words

Chlamydia - conjunctivitis - cat flu - feline upper respiratory tract disease - FURTD

• Literatur

• 1 Aronson AL. Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 1980; 176: 1061-1068.
• 2 Azuma Y, Hirakawa H, Yamashita A, Cai Y, Rahman MA, Suzuki H, Mitaku S, Toh H, Goto S, Murakami T, Sugi K, Hayashi H, Fukushi H, Hattori M, Kuhara S, Shirai M. Genome sequence of the cat pathogen, Chlamydophila felis . DNA Res 2006; 13: 15-23.
• 3 Baker JA. A virus causing pneumonia in cats and producing elementary bodies. J Exp Med 1944; 79: 159-171.
• 4 Baker JA. A virus obtained from a pneumonia of cats and its possible relation to the cause of atypical pneumonia in man. Science 1942; 49: 475-476.
• 5 Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL, Caldwell HD. Genomic transcriptional profiling of the developmen tal cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2003; 100: 8478-8483.
• 6 Bevelander G, Nakahara H. Correlation between tetracycline binding and mineralization in dentin and enamel. Anat Rec 1965; 153: 141-147.
• 7 Tier -ärzte e V. Hrsg Deutsche Impfempfehlungen für die Kleintierpraxis. Frankfurt am Main: Bundesverband Praktizierender Tierärzte e. V.; 2006
• 8 BPT. Ständige Impfkommission Vet. (StIKo Vet.) im Bundesverband praktizierender Tierärzte e. V Hrsg Leitlinie zur Impfung bei Kleintieren. Frankfurt am Main: Bundesverband praktizierender Tierärzte e. V.; 2009
• 9 Butaye P, Ducatelle R, De Backer P, Vermeersch H, Remon JP, Haesebrouck F. In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys. Antimicrob Agents Chemother 1997; 41: 2800-2801.
• 10 Carlborg B. Complications of drugs being accidentally dissolved in the esophagus and bronchi. Lakartidningen 1976; 73: 4201-4204.
• 11 Carlborg B, Densert O. Esophageal lesions caused by orally administered drugs. An experimental study in the cat. Eur Surg Res 1980; 12: 270-282.
• 12 Carlborg B, Densert O, Lindqvist C. Tetracycline induced esophageal ulcers. A clinical and experimental study. Laryngoscope 1983; 93: 184-187.
• 13 Cohlan SQ. Tetracycline staining of teeth. Teratology 1977; 15: 127-129.
• 14 Cohlan SQ, Bevelander G, Tiamsic T. Growth inhibition of prematures receiving tetracycline. Am J Dis Child 1963; 105: 453-461.
• 15 Cotton MM, Partridge MR. Infection with feline Chlamydia psittaci . Thorax 1998; 53: 75-76.
• 16 Danwitz BR, Rehmann SU. Beitrag zum Vorkommen und Nachweis von Chlamydieninfektionen bei der Katze. Tierärztl Umsch 1991; 8: 350-354.
• 17 Darougar S, John AC, Viswalingam M, Cornell L, Jones BR. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol 1978; 62: 709-714.
• 18 Darougar S, Viswalingam M, Treharne JD, Kinnison JR, Jones BR. Treatment of TRIC infection of the eye with rifampicin or chloramphenicol. Br J Ophthalmol 1977; 61: 255-259.
• 19 Darougar S, Viswalingam N, El-Sheikh H, Hunter PA, Yearsley P. A double-blind comparison of topical therapy of chlamydial ocular infection (TRIC infection) with rifampicin or chlortetracycline. Br J Ophthalmol 1981; 65: 549-552.
• 20 Davidson M. Information on adverse drug reaction in cats. J Am Vet Med Assoc 2001; 219: 1676
• 21 Dawson S, Willoughby K. Feline infectious upper respiratory tract disease – an update. In Pract 1999; 21: 232-237.
• 22 Dean R, Harley R, Helps C, Caney S, Gruffydd-Jones T. Use of quantitative real-time PCR to monitor the response of Chlamydophila felis infection to doxycycline treatment. J Clin Microbiol 2005; 43: 1858-1864.
• 23 Denamur E, Sayada C, Souriau A, Orfila J, Rodolakis A, Elion J. Restriction pattern of the major outer membrane protein gene provides evidence for a homogeneous invasive group among ruminant isolates of Chlamydia psittaci . J Gen Microbiol 1991; 137: 2525-2530.
• 24 Dhem A, Piret N, Fortunati D. Tetracyclines, doxycycline and calcified tissues. Scand J Infect Dis Suppl 1976; 42-46.
• 25 Djupesland G, Rolstad EA. Esophageal ulcerations caused by drugs. Tidsskr Nor Laegeforen 1978; 98: 696-697.
• 26 Donati M, Piva S, Di Francesco A, Mazzeo C, Pietra M, Cevenini R, Baldelli R. Feline ocular chlamydiosis: clinical and microbiological effects of topical and systemic therapy. New Microbiol 2005; 28: 369-372.
• 27 Dorin SE, Miller WW, Goodwin JK. Diagnosing and treating chlamydial conjunctivitis in cats. Vet Med 1993; 8: 322-330.
• 28 Elston T, Rodan I. Feline vaccination guidelines. Comp Contin Educ Prac Vet 1998; 20: 936-941.
• 29 Everett KD. Chlamydia and Chlamydiales: more than meets the eye. Vet Microbiol 2000; 75: 109-126.
• 30 Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999; 49: 415-440.
• 31 Gaskell RM, Dawson S. Feline respiratory disease. In: Infectious Diseases of the Dog and Cat Greene CE. ed Philadelphia: Saunders; 1998: 97-106.
• 32 Gelatt KN, van der Woerdt A, Ketring KL, Andrew SE, Brooks DE, Biros DJ, Denis HM, Cutler TJ. Enrofloxacin-associated retinal degeneration in cats. Vet Ophthalmol 2001; 4: 99-106.
• 33 Gerhardt N, Schulz BS, Werckenthin C, Hartmann K. Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. Vet Rec 2006; 159: 591-594.
• 34 German AJ, Cannon MJ, Dye C, Booth MJ, Pearson GR, Reay CA, Gruffydd-Jones TJ. Oesophageal strictures in cats associated with doxycycline therapy. J Feline Med Surg 2005; 7: 33-41.
• 35 Greene CE. Chlamydial infections. In: Infectious Diseases of the Dog and Cat Greene CE. ed St. Louis: Saunders Elsevier; 2006: 245-252.
• 36 Greene CE, Hartmann K, Calpin J. Antimicrobial drug formulary. In: Infectious Diseases of the Dog and Cat Greene CE. ed St.Louis: Saunders Elsevier; 2006: 1186-1333.
• 37 Griffiths PD, Lechler RI, Treharne JD. Unusual chlamydial infection in a human renal allograft recipient. Br Med J 1978; 2: 1264-1265.
• 38 Gruffydd-Jones T, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Rad-ford AD, Thiry E, Truyen U, Horzinek MC. Chlamydophila felis infection. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11: 605-609.
• 39 Hampshire VA, Doddy FM, Post LO, Koogler TL, Burgess TM, Batten PO, Hudson R, McAdams DR, Brown MA. Adverse drug event reports at the United States Food and Drug Administration Center for Veterinary Medicine. J Am Vet Med Assoc 2004; 225: 533-536.
• 40 Hartley JC, Stevenson S, Robinson AJ, Littlewood JD, Carder C, Cartledge J, Clark C, Ridgway GL. Conjunctivitis due to Chlamydophila felis (Chlamydia psittaci feline pneumonitis agent) acquired from a cat: case report with molecular characterization of isolates from the patient and cat. J Infect 2001; 43: 7-11.
• 41 Hartmann AD, Helps CR, Lappin MR, Werckenthin C, Hartmann K. Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections. J Vet Intern Med 2008; 22: 44-52.
• 42 Helps C, Reeves N, Egan K, Howard P, Harbour D. Detection of Chlamydophila felis and feline herpesvirus by multiplex real-time PCR analysis. J Clin Microbiol 2003; 41: 2734-2736.
• 43 Helps C, Reeves N, Tasker S, Harbour D. Use of real-time quantitative PCR to detect Chlamydophila felis infection. J Clin Microbiol 2001; 39: 2675-2676.
• 44 Helps CR, Lait P, Damhuis A, Bjornehammar U, Bolta D, Brovida C, Chab-anne L, Egberink H, Ferrand G, Fontbonne A, Pennisi MG, Gruffydd-Jones T, Gunn-Moore D, Hartmann K, Lutz H, Malandain E, Mostl K, Stengel C, Harbour DA, Graat EA. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec 2005; 156: 669-673.
• 45 Hof H, Dörries R. Chlamydiaceae. In: Medizinische Mikrobiologie Hof H, Dörries R. Hrsg Mannheim: Thieme; 2005: 447-451.
• 46 Hoover EA, Kahn DE, Langloss JM. Experimentally induced feline chlamydial infection (feline pneumonitis). Am J Vet Res 1978; 39: 541-547.
• 47 Kaufman AC, Greene CE. Increased alanine transaminase activity associated with tetracycline administration in a cat. J Am Vet Med Assoc 1993; 202: 628-630.
• 48 Keller SJ. Augenveränderungen bei der Katze durch Chlamydia psittaci . Kleintierprax 1988; 33: 157-160.
• 49 Majcherczyk J, Szymanska-Jachimczak EI. Discoloration of the teeth and bones in young animals caused by tetracycline. Zahnarztl Prax 1965; 16: 61-63.
• 50 Masubuchi K, Nosaka H, Iwamoto K, Kokubu T, Yamanaka M, Shimizu Y. Experimental infection of cats with Chlamydophila felis . J Vet Med Sci 2002; 64: 1165-1168.
• 51 McDonald M, Willett BJ, Jarrett O, Addie DD. A comparison of DNA amplification, isolation and serology for the detection of Chlamydia psittaci infection in cats. Vet Rec 1998; 143: 97-101.
• 52 McGrotty YL, Knottenbelt CM. Oesophageal stricture in a cat due to oral administration of tetracyclines. J Small Anim Pract 2002; 43: 221-223.
• 53 Melendez LD, Twedt DC, Wright M. Suspected doxycycline-induced esophagitis with esophageal stricture formation in three cats. Feline Pract 2000; 28: 10-12.
• 54 Messias A, Gekeler F, Wegener A, Dietz K, Kohler K, Zrenner E. Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electro-retinography. Doc Ophthalmol 2008; 116: 177-191.
• 55 Moulder JW. The relation of the psittacosis group (Chlamydiae) to bacteria and viruses. Annu Rev Microbiol 1966; 20: 107-130.
• 56 Nasisse MP, Guy JS, Stevens JB, English RV, Davidson MG. Clinical and la -boratory findings in chronic conjunctivitis in cats: 91 cases (1983-1991). J Am Vet Med Assoc 1993; 203: 834-837.
• 57 NOAH. Compendium of Data Sheets of Animal Medicines National Office of Animal Health Ltd.2009 www.noahcompendium.co.uk.
• 58 Opperbeck J. Nebenwirkungen bei der Therapie mit Tetracyclinen unter besonderer Berücksichtigung der Zahnschäden. Z Laryngol Rhinol Otol 1971; 50: 393-401.
• 59 Owen WM, Sturgess CP, Harbour DA, Egan K, Gruffydd-Jones TJ. Efficacy of azithromycin for the treatment of feline chlamydophilosis. J Feline Med Surg 2003; 5: 305-311.
• 60 PEI. Katzenimpfstoffe Paul-Ehrlich-Institut 2009 www.pei.de/nn_161790/ DE/arzneimittel/vet-mittel/katzen/katzen-node.html?__nnn=true
• 61 Ramsey DT. Feline Chlamydia and calicivirus infections. Vet Clin North Am Small Anim Pract 2000; 30: 1015-1028.
• 62 Regan RJ, Dathan JR, Treharne JD. Infective endocarditis with glomerulonephritis associated with cat Chlamydia (C. psittaci) infection. Br Heart J 1979; 42: 349-352.
• 63 Richmond SJ. The isolation of Chlamydia subgroup A (Chlamydia trachomatis) in irradiated McCoy cells. Med Lab Technol 1974; 31: 7-9.
• 64 Riviere JE, Spoo JW. Tetracycline antibiotics. In: Veterinary Pharmacology and Therapeutics Adams H. ed Ames: Iowa State University Press; 2001: 828-840.
• 65 Sande MA, Mandell GL. Tetracyclines and chloramphenicol. In: The Pharmacological Basis of Tetracyclines Godman LS, Gilman A. eds New York: Macmilian Publishing; 1980: 1181-1189.
• 66 Schachter J, Ostler HB, Meyer KF. Human infection with the agent of feline pneumonitis. Lancet 1969; 1: 1063-1065.
• 67 Schluter G. Ciprofloxacin: toxicologic evaluation of additional safety data. Am J Med 1989; 87: 37S-39S.
• 68 Schmeer N, Jahn GJ, Bialasiewicz AA, Weber A. Die Katze als mögliche In -fektionsquelle für Chlamydia-psittaci-bedingte Keratokonjunktivitis beim Menschen. Tierärztl Prax 1987; 15: 201-204.
• 69 Schulz B, Hupfauer S, Hartmann K. Side effects of doxycycline in cats. J Vet Intern Med 2008; 22: 1480
• 70 Selbitz H-J. Bakterielle Krankheiten der Tiere. In: Medizinische Mikrobiologie, Infektions- und Seuchenlehre Rolle M, Mayr A. Hrsg Stuttgart: Enke; 2002: 417-588.
• 71 Shewen PE, Povey RC, Wilson MR. A comparison of the efficacy of a live and four inactivated vaccine preparations for the protection of cats against experimental challenge with Chlamydia psittaci . Can J Comp Med 1980; 44: 244-251.
• 72 Siewert K, Rupp J, Klinger M, Solbach W, Gieffers J. Growth cycle-dependent pharmacodynamics of antichlamydial drugs. Antimicrob Agents Chemother 2005; 49: 1852-1856.
• 73 Sparkes AH, Caney SM, Sturgess CP, Gruffydd-Jones TJ. The clinical efficacy of topical and systemic therapy for the treatment of feline ocular chlamydiosis. J Feline Med Surg 1999; 1: 31-35.
• 74 Studdert MJ, Studdert VP, Wirth HJ. Isolation of Chlamydia psittaci from cats with conjunctivitis. Aust Vet J 1981; 57: 515-517.
• 75 Sturgess CP, Gruffydd-Jones TJ, Harbour DA, Jones RL. Controlled study of the efficacy of clavulanic acid-potentiated amoxycillin in the treatment of Chlamydia psittaci in cats. Vet Rec 2001; 149: 73-76.
• 76 Sykes JE. Feline upper respiratory tract pathogens: Chlamydophila felis . Comp Contin Educ Prac Vet 2001; 23: 231-241.
• 77 Sykes JE, Studdert VP, Anderson G, Browning GF. Comparison of Chlamydia psittaci from cats with upper respiratory tract disease by polymerase chain reaction analysis of the ompA gene. Vet Rec 1997; 140: 310-313.
• 78 Sykes JE, Studdert VP, Browning GF. Comparison of the polymerase chain reaction and culture for the detection of feline Chlamydia psittaci in untreated and doxycycline-treated experimentally infected cats. J Vet Intern Med 1999; 13: 146-152.
• 79 TerWee J, Sabara M, Kokjohn K, Sandbulte J, Frenchick P, Dreier KJ. Cha -racterization of the systemic disease and ocular signs induced by experimental infection with Chlamydia psittaci in cats. Vet Microbiol 1998; 59: 259-281.
• 80 Vrabec TR, Sergott RC, Jaeger EA, Savino PJ, Bosley TM. Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (Cipro). Ophthalmology 1990; 97: 707-710.
• 81 Wallman IS, Hilton HB. Teeth pigmented by tetracycline. Lancet 1962; 1: 827-829.
• 82 Wasmoen T, Wasmoen M. Demonstrated one year duration of immunity for an inactivated feline Chlamydia psittaci vaccine. Feline Pract 1992; 20: 13-16.
• 83 Waters L, Barnett KC. The eye. In: Feline Medicine and Therapeutics Chandler EA, Gaskell CJ, Gaskell RM. eds Oxford: Blackwell Publishing Ltd.; 2004: 455-492.
• 84 Watson PM. Idiosyncratic reaction to enrofloxacin in cats. Vet Rec 2002; 150: 556
• 85 Westfall DS, Twedt DC, Steyn PF, Oberhauser EB, VanCleave JW. Evaluation of esophageal transit of tablets and capsules in 30 cats. J Vet Intern Med 2001; 15: 467-470.
• 86 Wills JM, Gruffydd-Jones TJ, Richmond SJ, Gaskell RM, Bourne FJ. Effect of vaccination on feline Chlamydia psittaci infection. Infect Immun 1987; 55: 2653-2657.
• 87 Wills JM, Gruffydd-Jones TJ, Richmond SJ, Paul ID. Isolation of Chlamydia psittaci from cases of conjunctivitis in a colony of cats. Vet Rec 1984; 114: 344-346.
• 88 Wills JM, Howard PE, Gruffydd-Jones TJ, Wathes CM. Prevalence of Chlamydia psittaci in different cat populations in Britain. J Small Anim Pract 1988; 29: 327-339.
• 89 Wills JM, Millard WG, Howard PE. Evaluation of a monoclonal antibody based ELISA for detection of feline Chlamydia psittaci . Vet Rec 1986; 119: 418-420.
• 90 Zapirain Gastón J, Stengel C, Harbour D, Krieger S, Stampf S, Hartmann K. Prävalenz des felinen Herpesvirus-1, felinen Calicivirus und von Chlamydophila felis in Mehrkatzenhaushalten. Kleintierprax 2005; 49: 689-698.
• 91 Zrenner E, Messias A, Gekeler F. Pradofloxacin: an electroretinographic study on retinal toxicity in cats. Proceedings of the 1st International Veraflox ^® Symposium. Berlin: 2006: 30-31.